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Biological Engineering Program 
Faculty Mentor: Mahendra Kavdia 
Biological Engineering Program 
Biological and Agricultural Engineering 
Abstract 
Nitric oxide (NO) is inactivated in the human body when 
exposed to superoxide (02-;. This reaction forms peroxynitrite 
(ONOO). Superoxide is produced in the cardiac system by 
several mechanisms, including NAD(P)H oxidase. Superoxide 
dismutase (SOD) breaks down superoxide into oxygen and 
hydrogen peroxide. This prevents superoxide from reacting 
with nitric oxide and allows norma/function to take place. 
Superoxide and peroxynitrite are main contributors to vascular 
disease in the human bod); in particular hypertension. 
Experiments have shown that there is an increase of superoxide 
production in spontaneously hypertensive rats (SHR) vs. age-
matched Wistar Kyoto rats (WKY) that were normotensive. The 
increase in superoxide production intensifies in the presence of 
scavenger DETCA Cu2+ !Zn2+. A mathematical model has been 
developed by Kavdia and Popel to calculate concentrations 
of NO, ONOO·, and 0 2- in the arterial and venule pair. Using 
this model we calculated the arterial and venule NO, ONOO-, 
and 02- concentration profiles for normotension, hypertension, 
SOD inactivation, and NAD(P)H stimulated cases, and 
analyzed which specific regions showed amplification or 
reductions in concentrations. The inactivation of SOD allowed 
02- concentration to significantly increase by I 0-fold under 
basal conditions in hypertensive mice, while reducing the NO 
concentration in the model. Basilar arteries from hypertensive 
rats showed an increase of 4.1-fold in Nox4 compared to 
normotensive rats. The results suggest that the increase in 
superoxide in hypertensive rats is in correlation with the 
increase of NAD( P)H oxidase in these rats. The trends in 
superoxide production in this paper can help researchers and 
the medical community understand lz)pertension and vascular 
disease more thoroughly. Further, for future research, observed 
increases of Noxl and Nox4 expression suggest specific regions 
where 0 2- will be high and which need to be evaluated. 
Introduction 
Cardiovascular disease is the leading cause of death in the 
United States. According to the American Heart Association. 
this disease was responsible for taking over 870.000 lives in 
2005. Increased vascular production of reactive oxygen species 
(ROS) is a common characteristic of cardiovascular disease5. 
There are several factors that increase the risk of cardiovascular 
disease including hypertension, hypercholesterolemia, and 
diabetes mellitus6• In the United States, hypertension affects 
approximately 58 million Americans. 
Vascular and cardiac tissues are rich sources of ROS, 
including superoxide (02·), hydrogen peroxide (H,O,), and 
peroxynitrite (ON00-)7. Reactive oxygen species "ar~ the 
by-products of oxygen metabolism and are nonnally present 
in low levels of concentration inside the cells8• ROS are 
needed in aiding the signaling processes within the cells, and 
also in regulating vascular smooth muscle cell contraction 
and relaxation. Increasing amounts of 0 2- is the most 
common trend in vascular diseases, such as hypertension, 
because it causes oxidative stress in the vascular tissue9. 
One of the mechanisms for controlling oxidative stress in 
the vascular system is superoxide dismutase. Superoxide 
dismutase consumes 0 2-, and then converts it into less harmful 
compounds 10• 
The major sources of vascular superoxide include xanthine 
oxidase, nitric oxide synthases, mitochondrial oxidases, 
or NAD(P)H oxidases 11 • Each of these sources generates 
superoxide in a different mannerism in the human body. 
Xanthine oxidase (XO) is an iron sulfur flavoprotein 
that is found in high concentrations in the endothelial cells 
and plasma, but not in smooth muscle cellsl2. Xanthine 
generates the superoxide by catalyzing hypoanthine and 
xanthine to fonn uric acid. Nitric oxidase synthases (NOS), 
found predominantly in the endothelial cell region, play a 
major role in vascular diseases. Endothelial nitric oxidase 
synthases (eNOS) require tetrahydrobiopterin (BH-l) for the 
transfer of electrons to the nitrone of the L-arginine 12. This 
reaction under nonnal conditions fonns nitric oxide in the 
vessels. However, when BH~ is not present, eNOS generates 
0 2- and Hz02. Mitochondrial oxidases utilize the uncoupling of 
oxygen during mitochondrial oxidative phosphorylation, which 
occurs during the production of ATP, to synthesize o,-. The 
superoxide produced with lesion development in the arteries 
comes primarily from the mitochondrial oxidasel2. 
In particular, in the work reported here, we analyzed 
more closely the NAD(P)H oxidase as a source of vascular 
superoxide. NAD(P)H oxidases are present in endothelial cells, 
fibroblasts, smooth muscle cells, neutrophils, and phagocytic 
mononuclear cells2. The study of NAD(P)H started at the 
biochemical reaction of the compound in the cardiovascular 
system. NAD(P)H is a multi-subunit enzyme that catalyzes O,-
production by reducing oxygen by one electron and using the-
NAD(P)H as the electron donor7. 
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In addition, nitric oxide released by 
endothelial cells is a key chemical that 
regulates blood flow. In oxidative stress 
conditions the availability of nitric oxides 
Figure l. Data Results from Paravinici 
is reduced in vascular tissues, a process which is known as 
endothelial cell dysfunction 10. With this dysfunction comes 
the natural response of the human body to overcome this 
production of superoxide. Superoxide is neutralized by a group 
of antioxidant enzymes. These enzymes include SOD, CAT, 
GPx. and thiol-disulfide oxidoreductases 12• 
The research described here dealt primarily with 
SOD as the main antioxidant enzyme. There are at least 
three distinctive isoforms of SOD identified in humans: 
mitochondrial manganese-containing SOD (MnSOD, SOD2), 
the cytosolic copper/zinc-containing SOD (CuZnSOD, SODl) 
and the extracellular SOD (eSOD, SOD3)13. SOD dismutases 
superoxide to form hydrogen peroxide and oxygen. Loss of 
endothelial NO available to endothelial cells is caused by 
the reaction with o,-. This reaction forms ONOO-, which is 
a key component i; many cardiovascular diseases such as 
hypertension, diabetes, and atherosclerosis. Understanding 
the levels of nitric oxide, superoxide, and peroxynitrite should 
contribute to a better understanding of the diseases and the 
oxidative stress state of the vascular system. 
In 2004, Kavdia and Popel developed a mathematical 
model to create the concentration profiles for NO, ONOO-, and 
0,- for an arterial and venule pair during microcirculation 1. 
This model defines the geometry of the arterial and venule 
vessels parallel to each other, while using diffusion rates and 
chemical reaction rates to calculate the concentration profiles. 
The objective of this study was to predict NO, ONOO-, 
and 0,- concentration profiles for three different cases: 1) basal 
conditions compared to NAD(P)H stimulated conditions (2) 
basal conditions in normotensive and hypertensive rats with 
inactivation of SOD by DETCA (3) NAD(P)H stimulation 
in normotensive and hypertensive rats with inactivation of 
SOD by DETCA. We used data from Tamara Paravicini's 
"Increased NADPH-Oxidase Activity and Nox4 Expression 
during Chronic Hypertension is Associated with Enhanced 
Cerebral Vasodilatation to NADPH In Vivo"_ In their work, 
the arteries from Wistar-Kyoto rats (\VKY) were compared to 
spontaneously hypertensive rats (SHR). The 0 2· production in 
these arteries was measured by 5 Jtmol!L lucigenin-enhanced 
chemiluminescence under various conditions. The results from 
Paravicini's experiment are displayed in Figure I. The trends in 
these data were applied to the Kavdia and Popel model for the 
purpose of the current research. 
Methods 
Model Geometry 
A previous model by Kavdia and Popel was used to 
simulate arteriole/venule during microcirculation. This 
model contains six different regions in the vessels: red blood 
cell rich (CR), red blood cell free (CF), endothelium (E), 
interstitial space (IS), smooth muscle (SM), and a nonperfused 
parenchymal tissue (NPT). The parenchymal tissue (PT) is the 
region around the arteriole and venule pair. Figure 2 shows 
the arterial and venule vessel next to each other. The regions 
have increasing diameters for each separate layer. Nitric Oxide 
(NO) is produced at the luminal and abluminal surfaces of the 
endothelium 10. 
The steady-state mass transport equation (cylindrical 
conditions) can be used to solve for the NO mass transport 
because the convective transport of NO can be neglected and 
the NO profiles reach steady state within milliseconds10• 
D V2C. +" R . = 0 J J - L..J ],1 (2) 
In this equation, j represents the particular model of 
interest; Cj is the concentration; Dj is the diffusivity; and Rj.i 
stands for the production and consumption of the species due 
to chemical reactions. 
Arteriole Venule 
Figure :Z: Arterial/Venule Geometry 
Reference 10 (Kavdia M. A computational model for free radicals transport 
in the microcirculation. Antio:dd Redox Signal. 2006;8(7-8): 1103-1111.) 2
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Boundary Conditions 
Specific boundary conditions needed to be set to model 
this geometry and diffusion rates. At the outer edge of the PT, 
a zero-flux boundary condition was fixed, and at the interfaces 
with the endothelium, the release of NO and 0 2- were given by 
the following equations respectively 10• 
(3) 
ac. i acj .. en Q =D-1-'c __ D 
J J ar J ar 
(4) 
The NO and 0 2- concentration profiles in the vascular tissue 
were obtained from these equations. 
Chemical Reactions 
The chemical reactions that are involved in the different 
layers of the arterial and venule are a mixture of first and 
second order reactions. Each region is discussed in further 
detail in Kavdia's "Venular endothelium-derived NO can affect 
paired arteriole: a computational model" 14• The areas that are 
rich in red blood cells contain high levels of hemoglobin. This 
hemoglobin reacts at a high rate with the NO in the region, as 
seen in the following equation where kcR is the effective NO 
reaction rate constant. 
(5) 
In the CF region the chemical reactions are first order reactions 
because the hematocrit in this region is assumed to be zero10• 
RNo,cR = kcFCNo (6) 
In the remaining of the regions E, IS, and NPT the NO reaction 
is a second order reaction10• 
RNa, 1 = kozC2NoCm (7) 
Vascular smooth muscle sGC consumes the NO for the smooth 
muscle region (SM)10 • Therefore the second-order reaction is: 
RNo = ks~1 C2No (8) 
For the capillary-perfused PT region, the endothelial cells 
of the capillaries produce NO. For this region the reaction 
rate must take into account the amount of nitric oxide that is 
released by the capillary endothelial cell. 
(9) 
Each region is different. so each individual chemical reaction 
had to be considered when the model was derived. 
Parameter Values 
All parameters that were defined in the previous equations 
used in the model can be found in Table 1. The geometry of 
the arterial and venule vessels has been discussed in previous 
reports 1• The venule is assumed to be twice the size of the 
arteriole. The arteriole is 25 Jim and the venule is 50 Jill in 
diameter. This ratio was assumed due to the reported distance 
between the arteriole and venule vessels 15. The diffusivity 
rates of NO, 0 2-, and peroxynitrite were assumed to be 
constant across the geometry and equa\3.3 x JO·S, 2.8 x 10·5, 
and 2.6x 10·5 cm2/s respectively according to Table I. To 
determine the consumption of NO in CR region, Kavdia and 
Popel used a hematocrit of 0.45 in the region 1• The reaction 
rate for the consumption of NO is 1,270 s· 1 in the region9• The 
NO that is released by the capillary endothelial cell, kcap was 
determined using a hematocrit of 0.3 and a capillary volume of 
0.0146 cm3 for the mode\ 10 • The kcap calculated was 12.4 s· 1 
for this case 16• 
Table 1. Model Parameters 
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Numerical Solutions 
Flex POE 3.0 software was used for modeling the 
arteriolar and venular endothelial NO, 0 2-, and ONoo-
concentrations. Flex POE 3.0 is computer software that can be 
used for modeling and solving numerical problems. 
Simulations 
Tamara M. Paravicini's article "Increased NADPH-
Oxidase Activity and Nox4 Expression during Chronic 
Hypertension is Associated with Enhanced Cerebral 
Vasodilatation to NADPH In Vivo" demonstrated experimental 
trends in the production of superoxide (02-) in Wistar-Kyoto 
rats (WKY) and Spontaneously Hypertensive rats (SHR). This 
data was assumed for a model of the human arterial/venule 
microcirculation during normotension and hypertension. For 
the base case we used the whole tissue superoxide production 
as fraction c = 0.2 of NO production and used 10 pM of SOD. 
The first simulation involved an increase of o2- production 
by 22-fold due to the NADPH stimulation of the arteriolar 
and venule. For this case the new whole tissue superoxide 
production fraction of NO production was c = 4.4 The SOD 
remained at lOpM. The results of both the normotensive and 
hypertensive were compared for basal and NADPH stimulated 
vessels. 
The second simulation compared the three different basal 
conditions with a difference in the level of SOD. We used a 
condition with SOD of IOpM and a superoxide production 
fraction c = 0.2 and compared it to the normotensive and 
hypertensive basal condition with an inactivation of SOD. The 
experiment used Cu2+ chelating agent diethyldithiocarbarnic 
acid trihydrate (DETCA) to inactive the Cu2+JZn2+ SOD. We 
assumed that SOD was reduced and that the level changed 
from lOjtM to lJIM. In normotensive basal condition with 
reduction of SOD the superoxide production fraction remained 
at c = 0.2. For hypertensive basal conditions the superoxide 
production fraction was c = 2 due to a 10-fold increase in 
superoxide production. 
The third simulation compared the NAD(P)H stimulated 
hypertensive/normotensive vessels with the change in SOD. 
With SOD of lO ;tM, the normotensive and hypertensive 
vessels both had a superoxide production fraction of c = 4.4, 
which are 22-fold greater than the basal conditions. With 
DETCA reduction of SOD to 1 pM, the normotensive vessels 
had a superoxide production fraction of c = 8, which was a 
40-fold increase from the basal conditions. With DETCA 
reduction of SOD to 1 pM, the hypertensive vessels had a 
superoxide production fraction of c = 18.4, which was 2.3-fold 
greater than the normotensive NADPH stimulated conditions. 
Results 
Normotensive and Hypertensive Cases (Basal and NADPH 
excited) with SOD of IOp!U 
Profiles for the reactive oxidative species were generated 
according to the concentration values along the horizontal 
center axis of the geometry, as seen in Figure 2. The first 
vertical line on the graph at 0.975 ern represented the middle 
of the arterial vessel. The endothelial cell region was 5 pm, 
therefore the second line was hard to distinguish from the first 
because it was at 0.9775 em on the graph. The third vertical 
line represented the smooth muscle cell region in the arterial 
vessel. The fourth vertical line represented the middle of the 
venule vessel at 0.105 em on the graph. 
For the base case, we used normal parameters as described 
in the methods section. The plots of NO, 0 2-, and ONoo-
concentrations for the base case are displayed in Figures 3, 
4 and 5, respectively. In Figure 3, the NO production of the 
Basal hypertensive and Basal normotensive with SOD of 
10 pM is the same. This simulation of basal hypertensive 
and normostenive with SOD of 10 ttM had the highest NO 
concentration and the lowest 0 2- concentration. The NAD(P)H 
stimulated hypertensive and normotensive with SOD of lO pM 
were equal to each other. The NO concentration in the lumen 
of the CR region of both the arterial and venule was zero. As 
the NO profile approached the EN region, the concentration 
reached 100 nM. From that region, the NO concentration 
profile decreased back to 0 nM in the lumen of the venule 
vessel. The NAD(P)H stimulation during this case only 
caused a noticeable change in the NO profile in the IYf region 
surrounding the arterial and venule pair. 
120 
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Figure 3. NO CONCENTRATION PROFILE FOR CASE 1 
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Figure 4. ONOO" CONCENTRATION PROFlLE FOR CASE 1 
The ONoo- concentration profile showed a visible change 
in Figure 4 throughout the arterial and venule pair due to 4
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the NAD(P)H stimulation. This stimulation caused a 20-fold 
increase in the ONoo- concentration. In the SM region, the 
ONoo- concentration increased from I nM to 2.5 nM due to 
the NAD(P)H stimulation. The perioxynitrite concentration 
was 0 nM in the lumen of the venule vessel. 
The 0 2- concentration profile is shown in Figure 5. 
This concentration profile shows that there was an increase 
in superoxide production in both the arterial and venule EN 
region. The 0 2- concentration had a peak at 0.433 nM and 2.29 
nM in the arterial EN and venule EN, respectively. 
4 
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J 
..1.1. 
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to NADPH Stimulated SOD 
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Distance (em) 
Figure 5. 0 2- CONCENTRATION PROFILE FOR CASE 1 
Normotensive and Hypertensive Cases (Basal Only) with 
SOD being inactivated from 10 pM to 1 pM 
We modeled the concentration profile of NO, ONoo-, and 
02- for the basal case only of normotensive and hypertensive 
cases, but the SOD was reduced from IOpM to 1 JIM with 
DETCA Cu2+JZn2+. The nitric oxide production in the 
reduced SOD was lower than that of the 10 JIM SOD cases. 
Also the NO level for the hypertensive case with SOD of 1 
JIM was much lower than the normotensive case with SOD of 
lpM under basal conditions. Figure 6 shows that the highest 
120 
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------------ ~-----------· 40 
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Dlstanea(cm) 
Figure 6. NO CONCEI'<'TRATION PROFILE FOR CASE 2 
concentrations of the NO were 102.3 nM, 96.InM, and 89.05 
nM for Normotensive/Hypertensive basal case with SOD to 10 
pM, Normotensive basal case SOD to I pM, and Hypertensive 
basal case with SOD to I pM, respectively in the EN arterial 
regions. The hypertensive basal case with SOD to I pM shows 
a NO concentration that was 20 nM less in the PT surrounding 
region of the arterial/venule pair compared to normotensive 
vessels in the same case. 
The peroxynitrite concentration profile is shown in Figure 
7. The hypertensive vessel with SOD reduction to I JIM had 
the highest levels of ONoo-. This corresponds to the same 
case having the lowest levels of NO. The peak in the arterial 
vessel was in the EN and SM region. The concentration levels 
were 6.56 nM, 4.25 nM, and 0.647 nM in hypertensive basal 
case with SOD to I JIM, normotensive basal case with SOD 
to I pM, and normotensive/hypertensive basal case with SOD 
to 10 pM, respectively. The peaks for the venule EN and SM 
region were I7.8 nM, 15.6 nM, and 2.36 nM, respectively. 
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Figure 7. O~oo· CONCENTRATION PROFlLE FOR CASE 2 
The superoxide concentration profiles for these specific 
cases are in Figure 8. This profile demonstrates that SOD 
reduction caused an increase of superoxide in the vessels by 
14 
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asaf SOO Ill tau M 
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Figure 8. o 2- CO:-ICEI'<'TRATION PROFILE FOR CASE 2 
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10-fold in hypertensive vessels compared to the cases with 
SOD of 10 11M. In the hypertensive basal case with SOD 
reduced, the superoxide concentration was 1.81 nM and 
13.3 nM in arterial and venule EN region, respectively. In 
comparison the arterial and venule EN region of normotensive 
basal with an SOD level of 1 JIM had peaks of 1.54 nM and 
12.83 nM, respectively. 
Normotensive and Hypertensive Cases (NADPH excited) with 
SOD being inactivated from IO pM to I pM 
Finally the profile for the NO, ONoo-, and 0 2- for 
normotensive and hypertensive vessels under NAD(P)H 
excited conditions with SOD reduced from 10 JIM to lJIM. The 
hypertensive NAD(P)H excited vessels with an SOD of 1 JIM 
had the lowest concentration of nitric oxide. These results are 
shown in Figure 9. The endothelial region of the arterial vessel 
had the highest concentration of NO during microcirculation. 
During normotensive/hypertensive vessels with NAD(P)H 
stimulation and with SOD of 10 JIM, the concentration was 
99.6 nM. However, when SOD is reduced to 1 JIM, the NO 
concentration in normotensive was75.6 nM and in hypertensive 
was 65.2 nM. The lumen of both the arterial/venule pairs was 
reduced to 0 nM in all three cases. 
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Figure 9. NO CO:"'CEl'.'TRATION PROFILE FOR CASE 3 
The ONoo- concentration profile for the NAD(P)H 
cases with SOD reduction are presented in Figure 10. The 
reduced SOD, hypertensive vessels had the highest ONoo-
concentrations. The lowest concentrations of perioxynitrite 
were in the lumen of the venule. The highest concentrations 
of the ONoo- were in the EN and SM region of the venule 
vessel. The concentrations were 29.4 nM, 23.3 nM, and 
3.45 nM for the reduced SOD hypertensive, reduced SOD 
normotensive, and the 10 pM SOD normotensive/hypertensive, 
respectively. 
The superoxide concentration profile for the NAD(P)H 
cases is shown in Figure 1 L This profile shows that. when 
the SOD was reduced in the hypertensive vessels, the 0 2-
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Figure 10. ONOO" CONCENTRATION PROFILE FOR CASE 3 
concentration peaks in the EN and SM of both the arterial 
and venule vessels. The arterial EN concentration level 
0125 
was lower than that of the venule because in the arterial the 
superoxide levels dropped dramatically before these regions. 
In hypertensive vessels with SOD reduction, the arterial EN 
superoxide concentration was 4.4 nM and in the venule EN 
superoxide concentration was 17.5 nM. In normotensive 
vessels with SOD reduction, the arterial EN superoxide 
concentration was 2.9 nM and in the venule EN superoxide 
concentration was 14.9 nM. 
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Discussion 
Effects of SOD Inactivation 
SOD inactivation was shown to increase the superoxide 
production by 10-fold in Basal Hypertensive cases. This 
resulted in an increase in peroxynitrite but a decrease in the 
nitric oxide. SOD reduction with NAD(P)H stimulation caused 
an increase of 2.1-fold and 4.1-fold in superoxide production 
in normotensive and hypertensive vessels, respectively 
when compared to vessels with SOD of 10 JtM. When SOD 6
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was activated, the superoxide production was the same in 
hypertensive and normotensive vessels. This shows that SOD 
is very important in controlling 0 2- production and also in 
vascular disease. Without SOD, the level of superoxide may 
increase dramatically, potentially inducing vascular diseases 
When SOD is 10 JIM, the vessels have a higher than normal 
level of H20 2 due to the dismutase of superoxide. This 
explains why the levels of H20 2 in plasma are higher than in 
normotensive patients3• This level of H20 2, which is a powerful 
vasodilator, may have important consequences in the vascular 
system3. Current therapies for vascular disease, such as~­
blockers, angiotensin antagonists, and angiotensin-converting 
enzyme inhibitors, act like antioxidants in some way'7. New 
antioxidant therapies have the potential to be discovered to 
treat hypertension. 
Effects of Normotension vs. Hypertension 
Spontaneous hyptertensive vessels can cause a 10-fold 
increase from normotensive vessels in basal conditions and 
a 2.3-fold increase from normotensive vessels in NAD(P)H 
stimulated vessels. Our data show that superoxide production is 
increased dramatically in hypertensive vessels. In hypertensive 
basilar vessels the Nox4 was 4.1-fold higher3• This shows that 
there is a direct correlation between the increase of NAD(P)H 
oxidase in regions and the increase of production with 
superoxide and vasodilation. In the area directly before the EN 
region, the superoxide level decreases dramatically. However, 
in the endothelial region, there is a large increase in superoxide 
production. This can be explained because this is where Nox4 
is found to be most prevalent. Nox4 mRNA is seen to be 125 
-fold higher in endothelial cells than in smooth muscle cells2 
(see Table 2). 
(xHr'tiO'copies 18S) Nox4 Noll 
MGnoc)te Undct.:ctable 0.10 
Endothelial Cells 270.0 0.87 
Smooth Muscle Cells 2.15 0.22 
fibroblasts 6.25 0.45 
Table 2. EXPRESSION OF NOX ISO FORMS 
Also Nox4 and Noxl mRNA levels are 2.5-fold and 10-
fold greater in spontaneously hypertensive rats than in age-
matched Wistar Kyoto rats, respectively 18• Published data and 
the results from this model, showed a direct corrlation between 
superoxide production and Nox expression. 
Effects ofNAD(P)H stimulation 
When NAD(P)H was used to stimulate the vessels, it 
increased superoxide in the cells because the NAD(P)H 
reacted with the oxygen in the vessels. During this reaction, 
superoxide was produced, which significantly increased the 
levels of superoxide in the vessels. NAD(P)H stimulation 
increased the superoxide produce 22-fold compared to normal 
basal conditions when SOD was 10 JIM. During NAD(P)H 
stimulation when SOD was reduced to 1 JtM, the superoxide 
production was 40-fold higher and 92-fold higher for 
normotensive and hypertensive, respectively when compared to 
normal basal conditons. In human coronary arteries, NAD(PJH 
stimulation is the major source of superoxide production, and 
in human coronary artery disease the NAD(P)H acivity is 
significantly increased5 
Importance and Conclusion 
The purpose of this model was to provide additional 
information about oxidative stress in hypertension. During 
hypertension, there was an increase in superoxide production 
when SOD was decreased. The trends from the NO, ONOO·. 
and o2- concentration profile show us which regions were 
affected by the disease and the physiological affects on 
the walls of the arteriole and venule. In addition, the H20 2 
generated during superoxide dismutase may have a signifcant 
correlation to vasodilation during hypertension. The relevance 
of this research is underlined in the major role of oxidative 
stress in vascular diseases. The future of cardiovascular therapy 
is based on the balance between NO, ONOO-. and 0 2- within 
the body19• 
Future Work 
The data from this study could be used to further the 
understanding of vascular diseases. Nox 1 and Nox4 are 
highest in the endothelial and smooth muscle cell region. The 
NAD(P)H oxidases are also expressed more in hypertension 
than during normotension. As previously stated, the expression 
of Noxl is 10-fold greater and Nox4 is 2.5-fold greater. In 
recent years, there have been a number of publications about 
treating the arterioles and veins with different medications. 
Very similar tests have been done to measure superoxide 
production and Nox expression. 
In one particular experiment, the vessels were treated with 
different hypertension medications: I) high dose candcsartan 
2) low dose of candesartan 3) a dose of a combined hyralazine 
and hydrochlorothiazide 18• All three treatments reduced 
the expression of Noxl and Nox4. From the results of this 
modeling study, we can hypothesize that a reduction of Nox I 
and Nox4 will also reduce the superoxide levels produced in 
the arterial and venule flow. The data show that the strong 
correlation might suggest a stronger link between NAD(P}H 
stimulation and the development of vascular diseases. In 
future research, we plan to model the concentration profiles of 
medically treated vessels to evaluate the effects of the medicine 
on the NO, ONOO-. and 0 2- profiles. 
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Mentor Letter 
Mahendra Kavdia speaks highly of Aaron Strobel's academic 
excellence and of the importance of the research described in 
this article. 
Aaron started his research in my Laboratory in April, 
2007. He obtained his undergraduate degree in Biological 
Engineering with a concentration in Biomedical 
Engineering/PreMed May, 08. He is one of the best 
students in our Department. Though the long-term plan 
of Aaron is to pursue a MD degree, he had an internship 
offer at St. Jude, San Francisco, CA but decided to work 
in bioinformatics area at Little Rock, AR to better prepare 
him for his long-term goals of pursuing MD. Aaron was 
motivated to perform research. He wrote an honors 
proposal and got funded in Spring, 08. He participated 
in several research internships. The proposed research 
was to investigate the role of NADPH oxidase derived 
oxidative stress conditions on nitric oxide metabolism. 
This research is extremely important as oxidative stress 
is involved in numerous pathophysiological conditions 
such as cardiovascular diseases, diabetes, and aging. We 
had developed a computational model to understand the 
interaction of NADPH oxidase related oxidative stress 
on nitric oxide levels in vascular tissue. Aaron showed 
great initiative and also started communication with 
an experimental researcher in Australia to support his 
modeling research. His participation in my laboratory 
was very valuable for his basic knowledge of Biomedical 
Engineering and hands-on experience. Publication of this 
article in Inquiry certainly is a worthwhile recognition for 
Aaron's work and he deserves this. 
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